Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Genworth: Growth Prospects Bright, Low Interest Rates A Drag

Published 06/14/2016, 10:18 PM
Updated 07/09/2023, 06:31 AM

On Jun 14, 2016, we issued an updated research report on Genworth Financial, Inc. (NYSE:GNW) .

The life insurer’s first-quarter 2016 earnings outperformed the Zacks Consensus Estimate but declined year over year. The company recorded lower revenues owing to a decline in premiums and policy fees as well as an increase in expenses during the first quarter. Moreover, the company stalled sales of traditional life insurance and fixed-annuity products in the first quarter.

Genworth remains focused on its mortgage insurance business and on the process of separating long-term care businesses. In addition, the life insurer is strategically making divestments to streamline its businesses. Such asset sales are expected to improve performance, enhance financial and strategic flexibility, strengthen mortgage insurance, increase excess capital, earnings and return on equity (ROE) and restructure the US Life business.

Also, the company intends to rationalize costs for annual cash savings. This apart, Genworth expects annualized cash expense reductions of $150 million or more by second-quarter 2016.

Solid performance by the mortgage division has boosted the company’s dividend receipts. For 2016, Genworth expects dividends between $100 million and $150 million. However, the company’s capital management efforts could raise dividend to $200 million in 2016. Dividends from Canada and Australia are projected between $100 million and $150 million in 2016.

However, exposure to a low interest rate environment has been weighing on the company’s investment results, which is not expected to show substantial improvement any time soon.

Zacks Rank and Stocks to Consider

Currently, Genworth carries a Zacks Rank #3 (Hold). Some better-ranked life insurers are Manulife Financial Corporation (NYSE:MFC) , Health Insurance Innovations, Inc. (NASDAQ:HIIQ) and GWG Holdings, Inc. (NASDAQ:GWGH) . While both Manulife and Health Insurance Innovations sport a Zacks Rank #1 (Strong Buy), GWG Holdings holds a Zacks Rank #2 (Buy).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>



MANULIFE FINL (MFC): Free Stock Analysis Report

GENWORTH FINL (GNW): Free Stock Analysis Report

HEALTH INS INN (HIIQ): Free Stock Analysis Report

GWG HOLDINGS (GWGH): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.